Home Antibody All anti-MAP3K8 antibodies
Anti-MAP3K8 GAT Antibody Polyclonal
Generated by Genomic Immunization
Also for MAP3K8 (NM_005204)
|DNA immunization. This antibody is specific for the Middle Region of the target protein.|
|| WB 1:20000,ELISA 1:100-1:2000
|20 mM Potassium Phosphate, 150 mM Sodium Chloride, pH 7.0|
|The fragment used for DNA immunization was expressed in E.coli and the purified protein fragment was used for affinity purification of the antibody.
|This antibody was generated by SDIX's Genomic Antibody Technology ® (GAT). Learn about GAT
|Homo sapiens mitogen-activated protein kinase kinase kinase 8 (MAP3K8), transcript variant 1|
|c-COT; COT; EST; ESTF; MEKK8; Tpl-2; TPL2|
Entrez Gene 1326 Human
|TPL-2, a MEK kinase is essential for TLR4 activation of the ERK mitogen-activated protein kinase cascade in lipopolysaccharide (LPS)-stimulated macrophages. Interaction with p105 is required to maintain TPL-2 metabolic stability and also negatively regulates TPL-2 MEK kinase activity (1). The NF-kappaB1 gene encodes a larger precursor protein, p105, from which p50 is produced constitutively by proteasome-mediated removal of the p105 carboxy terminus. TPL-2 , which is homologous to MAP-kinase-kinase kinases in its catalytic domain, forms a complex with the carboxy terminus of p105. TPL-2 was originally identified, in a carboxy-terminal-deleted form, as an oncoprotein in rats and is more than 90% identical to the human oncoprotein COT. Expression of TPL-2 results in phosphorylation and increased degradation of p105 while maintaining p50 production. This releases associated Rel subunits or p50-Rel heterodimers to generate active nuclear NF-kappaB. Furthermore, kinase-inactive TPL-2 blocks the degradation of p105 induced by tumor-necrosis factor-alpha. TPL-2 is therefore a component of a new signaling pathway that controls proteolysis of NF-kappaB1 p105 (2).|
|Protein KinaseDruggable Genome MAPK signaling pathwayToll-like receptor signaling pathwayT cell receptor signaling pathway|
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.